Key Insights

Highlights

Success Rate

97% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

1.6%

1 terminated out of 62 trials

Success Rate

97.1%

+10.6% vs benchmark

Late-Stage Pipeline

21%

13 trials in Phase 3/4

Results Transparency

15%

5 of 33 completed with results

Key Signals

5 with results97% success

Data Visualizations

Phase Distribution

49Total
Not Applicable (26)
P 1 (3)
P 2 (7)
P 3 (8)
P 4 (5)

Trial Status

Completed33
Unknown13
Recruiting8
Not Yet Recruiting6
Terminated1
Enrolling By Invitation1

Trial Success Rate

97.1%

Benchmark: 86.5%

Based on 33 completed trials

Clinical Trials (62)

Showing 20 of 20 trials
NCT06219538Not ApplicableCompleted

DAISY Uterine Drain Device Evaluation

NCT05977686RecruitingPrimary

Hemoglobin Testing in Pregnant Patients

NCT06968481Phase 2Not Yet RecruitingPrimary

Sublingual Oxytocin for the Prevention of Post-partum Hemorrhage

NCT06333340Not ApplicableRecruitingPrimary

Comparative Efficacy of Carbetocin and Oxytocin in Parturients at Risk of Atonic Postpartum Hemorrhage Undergoing Elective Cesarean Delivery

NCT05370820Phase 2RecruitingPrimary

Prevention of Postpartum Hemorrhage With Tranexamic Acid

NCT07318467Not ApplicableNot Yet RecruitingPrimary

Prophylactic Regimen of Intravenous Oxytocin, Intravenous Tranexamic Acid, and Intramuscular Ergot Derivative for Primary Prevention of Postpartum Hemorrhage in Intrapartum Cesarean Section Versus Intravenous Carbetocin Alone

NCT06255496Completed

QStat Cartridge in Obstetric Patients

NCT05488457Phase 2RecruitingPrimary

Oxytocin Pharmacokinetics and Pharmacodynamics

NCT06513351Not ApplicableRecruitingPrimary

A Pragmatic Randomized Controlled Trial to Predict Postpartum Hemorrhage

NCT04117243Phase 2CompletedPrimary

Tranexamic Acid Versus Sublingual Misoprostol in Reducing Blood Loss During Elective CS in High Risk Cases

NCT06351969Not Yet RecruitingPrimary

Evaluating Placental Thickness and Thickness of Uterine Muscle at Placenta Attachment in Prediction of Postpartum Blood Loss in Placenta Accreta

NCT05312658Not ApplicableEnrolling By InvitationPrimary

Aortic Compression Trial to Reduce Blood Loss at Cesarean Section

NCT07002749Phase 1Not Yet RecruitingPrimary

ROLE OF PROPHYLACTIC TRANEXAMIC ACID IN PREVENTION OF POST-PARTUM HEMORRHAGE IN ELLSCS

NCT06898034Recruiting

Postpartum Ultrasound Evaluation to Assess Risk of Hemorrhage

NCT06604325Not ApplicableRecruitingPrimary

Prophylactic Tranexamic Acid To Reduce Blood Loss During Caesarean Delivery.

NCT06253832Not ApplicableCompleted

Conservative Management of Placenta Accreta Spectrum

NCT04364386Not ApplicableCompletedPrimary

Feasibility Clinical Investigation Using the InPress Device for the Treatment of Postpartum Hemorrhage

NCT06010368Phase 3Not Yet Recruiting

Comparing Intramyometrial Tranexamic Acid and Oxytocin for Blood Loss in Cesarean Section

NCT06577922Not ApplicableRecruitingPrimary

Evaluation of Maternal & Newborn Health Simulation Lab Centers of Excellence in Nepal

NCT06560099Not ApplicableNot Yet RecruitingPrimary

Standard Oxytocin Versus High Dose Oxytocin to Control Postpartum Hemorrhage in High Risk Pregnancy During Elective Cesarean Section

Scroll to load more

Research Network

Activity Timeline